Peter Salzmann

Board Member

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

IMVT

Current role

Board Member, CEO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2026	Immunovant, Inc. (IMVT)	Former Chief Executive Officer	$39,614	—	$8,287,949	$6,269,395	—	$737,642	$15,334,600
2025	Immunovant, Inc. (IMVT)	Former Chief Executive Officer	$724,500	$470,925	$4,941,237	$4,539,890	—	$55,575	$10,732,127
2024	Immunovant, Inc. (IMVT)	Former Chief Executive Officer	$700,000	$609,000	$3,584,330	$3,619,675	—	$39,425	$8,552,430
2023	Immunovant, Inc. (IMVT)	Former Chief Executive Officer	$625,000	$360,938	$2,251,807	$2,544,313	—	$37,760	$5,819,818
2022	Immunovant, Inc. (IMVT)	M.D., M.B.A. Chief Executive Officer	$600,000	$346,500	$3,999,997	$888,389	—	$33,455	$5,868,341
2021	Immunovant, Inc. (IMVT)	M.D., M.B.A. Chief Executive Officer	$567,000	$311,850	$3,252,500	$11,104,950	—	$139,004	$15,375,304
2019	Immunovant, Inc. (IMVT)	M.D., M.B.A. Chief Executive Officer	$361,010	$500,000	—	$7,721,344	$224,480	—	$8,806,834

No earnings-call appearances or filed executive changes recorded yet.